Literature DB >> 22448757

Comparative structural effects of HIV-1 Gag and nucleocapsid proteins in binding to and unwinding of the viral RNA packaging signal.

Neil M Bell1, Julia C Kenyon, Shankar Balasubramanian, Andrew M L Lever.   

Abstract

The major RNA binding region of the HIV-1 Gag polyprotein is the nucleocapsid (NC) domain, which is responsible for the specific capture of the genomic RNA genome during viral assembly. The Gag polyprotein has other RNA chaperone functions, which are mirrored by the isolated NC protein after physiological cleavage from Gag. Gag, however, is suggested to have superior nucleic acid chaperone activity. Here we investigate the interaction of Gag and NC with the core RNA structure of the HIV-1 packaging signal (Ψ), using 2-aminopurine substitution to create a series of modified RNAs based on the Ψ helix loop structure. The effects of 2-aminopurine substitution on the physical and structural properties of the viral Ψ were characterized. The fluorescence properties of the 2-aminopurine substitutions showed features consistent with the native GNAR tetraloop. Dissociation constants (K(d)) of the two viral proteins, measured by fluorescence polarization (FP), were similar, and both NC and Gag affected the 2-aminopurine fluorescence of bases close to the loop binding region in a similar fashion. However, the influence of Gag on the fluorescence of the 2-aminopurine nucleotides at the base of the helix implied a much more potent helix destabilizing action on the RNA stem loop (SL) versus that seen with NC. This was further supported when the viral Ψ SL was tagged with a 5' fluorophore and 3' quencher. In the absence of any viral protein, minimal fluorescence was detected; addition of NC yielded a slight increase in fluorescence, while addition of the Gag protein yielded a large change in fluorescence, further suggesting that, compared to NC, the Gag protein has a greater propensity to affect RNA structure and that Ψ helix unwinding may be an intrinsic step in RNA encapsidation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22448757     DOI: 10.1021/bi2017969

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  12 in total

Review 1.  Advances in targeting nucleocapsid-nucleic acid interactions in HIV-1 therapy.

Authors:  Divita Garg; Bruce E Torbett
Journal:  Virus Res       Date:  2014-07-12       Impact factor: 3.303

Review 2.  HIV Genome-Wide Protein Associations: a Review of 30 Years of Research.

Authors:  Guangdi Li; Erik De Clercq
Journal:  Microbiol Mol Biol Rev       Date:  2016-06-29       Impact factor: 11.056

3.  In virio SHAPE analysis of tRNA(Lys3) annealing to HIV-1 genomic RNA in wild type and protease-deficient virus.

Authors:  Elias Seif; Meijuan Niu; Lawrence Kleiman
Journal:  Retrovirology       Date:  2015-05-16       Impact factor: 4.602

4.  Targeting RNA-protein interactions within the human immunodeficiency virus type 1 lifecycle.

Authors:  Neil M Bell; Anne L'Hernault; Pierre Murat; James E Richards; Andrew M L Lever; Shankar Balasubramanian
Journal:  Biochemistry       Date:  2013-12-10       Impact factor: 3.162

5.  Mechanistic differences between HIV-1 and SIV nucleocapsid proteins and cross-species HIV-1 genomic RNA recognition.

Authors:  Klara Post; Erik D Olson; M Nabuan Naufer; Robert J Gorelick; Ioulia Rouzina; Mark C Williams; Karin Musier-Forsyth; Judith G Levin
Journal:  Retrovirology       Date:  2016-12-29       Impact factor: 4.602

Review 6.  From Entry to Egress: Strategic Exploitation of the Cellular Processes by HIV-1.

Authors:  Pavitra Ramdas; Amit Kumar Sahu; Tarun Mishra; Vipin Bhardwaj; Ajit Chande
Journal:  Front Microbiol       Date:  2020-12-04       Impact factor: 5.640

Review 7.  Wrapping up the bad news: HIV assembly and release.

Authors:  Bo Meng; Andrew Ml Lever
Journal:  Retrovirology       Date:  2013-01-10       Impact factor: 4.602

8.  A novel combined RNA-protein interaction analysis distinguishes HIV-1 Gag protein binding sites from structural change in the viral RNA leader.

Authors:  Julia C Kenyon; Liam J Prestwood; Andrew M L Lever
Journal:  Sci Rep       Date:  2015-10-09       Impact factor: 4.379

9.  In-gel probing of individual RNA conformers within a mixed population reveals a dimerization structural switch in the HIV-1 leader.

Authors:  Julia C Kenyon; Liam J Prestwood; Stuart F J Le Grice; Andrew M L Lever
Journal:  Nucleic Acids Res       Date:  2013-08-08       Impact factor: 16.971

10.  An RNA-binding compound that stabilizes the HIV-1 gRNA packaging signal structure and specifically blocks HIV-1 RNA encapsidation.

Authors:  Carin K Ingemarsdotter; Jingwei Zeng; Ziqi Long; Andrew M L Lever; Julia C Kenyon
Journal:  Retrovirology       Date:  2018-03-14       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.